Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine.
作者信息
Panduro Arturo
机构信息
Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde" and Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico.
出版信息
Ann Hepatol. 2021 Jan-Feb;20:100293. doi: 10.1016/j.aohep.2020.100293.
Abstract
摘要
相似文献
1
Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine.《2020年病毒与肝脏：在新冠疫情之前及医学新时代的开端》
Ann Hepatol. 2021 Jan-Feb;20:100293. doi: 10.1016/j.aohep.2020.100293.
2
Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2.唾液作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）逆转录聚合酶链反应检测样本的准确性和稳定性。
J Clin Pathol. 2021 Jan;74(1):67-68. doi: 10.1136/jclinpath-2020-206972. Epub 2020 Sep 14.
3
Meeting the challenge of long COVID.应对长期新冠的挑战。
Nat Med. 2020 Dec;26(12):1803. doi: 10.1038/s41591-020-01177-6.
4
SARS 2 human coronavirus (COVID -19, SARS CoV2).严重急性呼吸综合征冠状病毒2（新冠病毒，SARS-CoV-2）
Dis Mon. 2020 Sep;66(9):101063. doi: 10.1016/j.disamonth.2020.101063. Epub 2020 Jul 28.
5
Lessons Learned at a COVID-19 designated hospital.在新冠病毒指定医院获得的经验教训。
Am J Surg. 2021 Jan;221(1):62-64. doi: 10.1016/j.amjsurg.2020.07.029. Epub 2020 Aug 4.
6
COVID-19 testing processes and patient protections for resumption of elective surgery.新冠病毒病（COVID-19）检测流程及恢复择期手术时的患者保护措施。
Am J Surg. 2021 Jan;221(1):49-52. doi: 10.1016/j.amjsurg.2020.07.009. Epub 2020 Jul 18.
7
A rational approach to COVID-19.对 COVID-19 的理性应对。
Hum Genomics. 2020 Dec 22;14(1):47. doi: 10.1186/s40246-020-00300-5.
8
The COVID-19 epidemic of manuscripts.关于新冠肺炎的稿件
J Adv Nurs. 2020 Oct;76(10):2454-2455. doi: 10.1111/jan.14437. Epub 2020 Jun 12.
9
What Sepsis Researchers Can Learn from COVID-19.脓毒症研究人员能从新冠病毒病中学到什么。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):125-127. doi: 10.1164/rccm.202010-4023LE.
10
COVID-19: The Patients' Perspectives.新冠肺炎：患者视角
Transplantation. 2021 Jan 1;105(1):4-5. doi: 10.1097/TP.0000000000003525.
引用本文的文献
1
Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico.墨西哥肝病学中预防慢性肝病的个性化医疗与营养
Front Nutr. 2024 May 9;11:1379364. doi: 10.3389/fnut.2024.1379364. eCollection 2024.
2
Milestones in the discovery of hepatitis C.丙型肝炎发现史的里程碑。
World J Gastroenterol. 2022 Oct 7;28(37):5395-5402. doi: 10.3748/wjg.v28.i37.5395.
本文引用的文献
1
COVID-19 in Latin America: Symptoms, Morbidities, and Gastrointestinal Manifestations.拉丁美洲的新冠疫情：症状、发病率及胃肠道表现
Gastroenterology. 2021 Feb;160(3):938-940. doi: 10.1053/j.gastro.2020.10.033. Epub 2020 Nov 6.
2
Virologists who discovered hepatitis C win medicine Nobel.发现丙型肝炎的病毒学家获得诺贝尔医学奖。
Nature. 2020 Oct;586(7829):348. doi: 10.1038/d41586-020-02763-x.
3
COVID-19 and the liver: What do we know after six months of the pandemic?COVID-19 与肝脏：大流行六个月后我们了解多少？
Ann Hepatol. 2020 Nov-Dec;19(6):590-591. doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.
4
Hepatology and the "new reality" ushered in by the COVID-19 pandemic.肝病学与2019年冠状病毒病大流行带来的“新现实”。
Ann Hepatol. 2020 Sep-Oct;19(5):449-450. doi: 10.1016/j.aohep.2020.08.060. Epub 2020 Sep 2.
5
SARS-CoV-2 another kind of liver aggressor, how does it do that?SARS-CoV-2 是另一种肝脏侵袭者，它是如何做到这一点的？
Ann Hepatol. 2020 Nov-Dec;19(6):592-596. doi: 10.1016/j.aohep.2020.08.062. Epub 2020 Aug 25.
6
Personalized medicine in Latin America.拉丁美洲的个性化医疗。
Per Med. 2020 Sep;17(5):339-343. doi: 10.2217/pme-2020-0049. Epub 2020 Aug 17.
7
Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology.远程医疗、COVID-19与肝脏疾病：重塑肝病学中的远程护理举措
Ann Hepatol. 2020 Jul-Aug;19(4):339-340. doi: 10.1016/j.aohep.2020.05.002. Epub 2020 May 23.
8
The liver in times of COVID-19: What hepatologists should know.COVID-19 时期的肝脏：肝病学家应该了解的知识。
Ann Hepatol. 2020 Jul-Aug;19(4):353-358. doi: 10.1016/j.aohep.2020.05.001. Epub 2020 May 18.
9
Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?直接抗病毒药物（DAAs）引入后丙型肝炎研究的重点在哪里：了解、认识、预防还是治愈丙型肝炎？
Ann Hepatol. 2020 Mar-Apr;19(2):119-120. doi: 10.1016/j.aohep.2020.02.002.
10
Hepatitis C virus clearance and less liver damage in patients with high cholesterol, low-density lipoprotein cholesterol and ε allele.高胆固醇、低密度脂蛋白胆固醇和 ε 等位基因的患者丙型肝炎病毒清除率更高，肝损伤更小。
World J Gastroenterol. 2019 Oct 14;25(38):5826-5837. doi: 10.3748/wjg.v25.i38.5826.
Zotero 插件